Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Othman Al-SawafCan ZhangHyun Yong JinSandra RobrechtYoonha ChoiSandhya BalasubramanianAlex KotakYi Meng ChangAnna Maria FinkEugen TauschChristof SchneiderMatthias RitgenKarl-Anton KreuzerBrenda ChylaJoseph N PaulsonChristian P PallaschLukas P FrenzelMartin PeiferBarbara EichhorstStephan StilgenbauerYanwen JiangMichael HallekKirsten FischerPublished in: Nature communications (2023)